ESS - CF - Posters apresentados em eventos científicos
Permanent URI for this collection
Browse
Browsing ESS - CF - Posters apresentados em eventos científicos by Author "Amorim, Manuela"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Antipsychotic therapy and biochemical laboratory profile characterization of a sample of patients diagnosed with schizophreniaPublication . Amorim, Manuela; Moreira, A.; Condeço, Jorge; Monteiro, Pedro; Marques, António; Summavielle, TeresaSchizophrenia (SCZ) patients are reported to present significant abnormalities in lipid and glucose metabolism, that increase the risk for cardiovascular disease and diabetes, possibly induced by antipsychotic therapy (APT) and lifestyle.
- Effects of one session of physical exercise associated to abdominal microcurrent in the global lipolytic ratePublication . Vilarinho, Rui; Noites, Andreia; Couto, Miriam; Monteiro, Pedro; Melo, Cristina; Amorim, Manuela; Moreira, AnabelaDuring aerobic exercise lipid sources are global. Since the decrease of central obesity has more health gains, it's important to promote an increase in lipolysis from the abdominal region. Analyze the effect of one session of aerobic exercise associated to microcurrent in the adipose tissue of abdominal region in the global lipolytic rate through the values of glycerol in plasma.
- Peripheral metabolism in rat with olanzapine subchronic treatment supplemented with acetyl-L carnitinePublication . Amorim, Manuela; Silva, Ana Isabel; Alves, Cecília Juliana; Monteiro, Pedro R.; Magalhães, Ana; Summavielle, TeresaOlanzapine (Olz) have been reported to promote higher risk for metabolic side-effects, such as obesity, dyslipidemia, and diabetes. Moreover/On the other hand, acetyl-L-carnitine (ALC) has been reported to improve homeostasis. This study aims to explore if ALC could improve metabolic homeostasis due to Olz effects on a rodent model. We investigated the effects of subchronic administration of Olz and with the addition of ALC on body weight gain and glucose metabolism in Wistar rats. Mid-term Olz exposure in rats significantly increases blood glucose levels in fasting and after the overload of glucose compared to the sali-ne-treated group (p<0.05). However, in rats mid-term treated with olanzapine plus acetyl-L-carnitine had no significant differences in fasting blood glucose levels compared to the saline-treated group. The findings suggest that ALC added to Olz treatment appeared to be effective to improve glucose metabolism during olanzapine subchronic treatment.